Atas, U. Et Al. 2024. Survival Outcomes of Patients with Primary Plasma Cell Leukemia in the Era of Proteasome Inhibitors and Immunomodulatory Agents: A Real-Life Multicenter Analysis.. Turkish journal of haematology : official journal of Turkish Society of Haematology .

Atas, U., Salim, O., Iltar, U., Yucel, O. K., Kucukdiler Eroglu, A. H., Aslan, V., ... Yildirim, M.(2024). Survival Outcomes of Patients with Primary Plasma Cell Leukemia in the Era of Proteasome Inhibitors and Immunomodulatory Agents: A Real-Life Multicenter Analysis.. Turkish journal of haematology : official journal of Turkish Society of Haematology .

Atas, Unal Et Al. "Survival Outcomes of Patients with Primary Plasma Cell Leukemia in the Era of Proteasome Inhibitors and Immunomodulatory Agents: A Real-Life Multicenter Analysis.," Turkish journal of haematology : official journal of Turkish Society of Haematology , 2024

Atas, Unal Et Al. "Survival Outcomes of Patients with Primary Plasma Cell Leukemia in the Era of Proteasome Inhibitors and Immunomodulatory Agents: A Real-Life Multicenter Analysis.." Turkish journal of haematology : official journal of Turkish Society of Haematology , 2024

Atas, U. Et Al. (2024) . "Survival Outcomes of Patients with Primary Plasma Cell Leukemia in the Era of Proteasome Inhibitors and Immunomodulatory Agents: A Real-Life Multicenter Analysis.." Turkish journal of haematology : official journal of Turkish Society of Haematology .

@article{article, author={Unal Atas Et Al. }, title={Survival Outcomes of Patients with Primary Plasma Cell Leukemia in the Era of Proteasome Inhibitors and Immunomodulatory Agents: A Real-Life Multicenter Analysis.}, journal={Turkish journal of haematology : official journal of Turkish Society of Haematology}, year=2024}